Association of plasma homocysteine with serum interleukin-6 and C-peptide levels in patients with type 2 diabetes

Metabolism: Clinical and Experimental

Volumn 54, Issue 6, 2005, Pages 809-814

  Araki, Atsushi ^a   Hosoi, Takayuki ^a   Orimo, Hajime ^a   Ito, Hideki ^b  

^a Tokyo Metropolitan Institute of Gerontology   (Japan)

^b Tokyo Metropolitan Tama Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BIOCHEMICAL MARKER; C PEPTIDE; C REACTIVE PROTEIN; CREATININE; CYANOCOBALAMIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INTERLEUKIN 6; TRIACYLGLYCEROL;

AGED; AMINO ACID BLOOD LEVEL; ARTICLE; ATHEROGENESIS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CREATININE BLOOD LEVEL; DISEASE MARKER; FEMALE; GENETIC ASSOCIATION; GENOTYPE PHENOTYPE CORRELATION; HOMOZYGOSITY; HUMAN; INNATE IMMUNITY; LINEAR REGRESSION ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SAMPLE SIZE; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HOMOCYSTEINE; HUMANS; INTERLEUKIN-6; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MULTIVARIATE ANALYSIS;

EID: 19444378109     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2005.02.001     Document Type: Article

References (34)

1. R. Clarke, L. Daly, K. Robinson, E. Naughten, S. Cahalane, and B. Fowler Hyperhomocysteinemia, an independent risk factor for vascular disease N Engl J Med 324 1991 1149 1155
2. B.M. Coull, M.R. Malinow, N. Beamer, G. Sexon, F. Nordt, and P. de Garmo Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke Stroke 21 1990 572 576
3. I.J. Perry, H. Refsum, R.W. Morris, S.B. Ebrahim, P.M. Ueland, and A.G. Shaper Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men Lancet 346 1995 1395 1398
4. A. Araki, Y. Sako, and H. Ito Plasma homocysteine concentrations in Japanese patients with non-insulin-dependent diabetes mellitus: effect of parenteral methyl-cobalamin treatment Atherosclerosis 103 1993 149 157
5. A. Araki, H. Ito, T. Hosoi, T. Majima, and H. Orimo Plasma homocysteine and asymptomatic cerebral infarction in elderly diabetic patients Geriatr Gerontol Int 3 2002 15 23
6. S.R. Lentz Homocysteine and vascular dysfunction Life Sci 61 1997 1205 1215
7. J.C. Pickup Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes Diabetes Care 27 2004 813 823
8. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
9. A.M. Bennet, J.A. Prince, G.Z. Fei, L. Lyrenas, Y. Huang, and B. Wiman Interleukin-6 serum levels and genotypes influence the risk for myocardial infarction Atherosclerosis 171 2003 359 367
10. B.B. Duncan, M.I. Schmidt, J.S. Pankow, C.M. Ballantyne, D. Couper, and A. Vigo Atherosclerosis Risk in Communities Study. Low-grade systemic inflammation and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study Diabetes 52 2003 1799 1805
11. P.J. Klover, T.A. Zimmers, L.G. Koniaris, and R.A. Mooney Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice Diabetes 52 2003 2784 2789
12. J.J. Senn, P.J. Klover, I.A. Nowak, and R.A. Mooney Interleukin-6 induces cellular insulin resistance in hepatocytes Diabetes 51 2002 3391 3399
13. S. Sandler, K. Bendtzen, D.L. Eizirik, and M. Welsh Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro Endocrinology 126 1990 1288 1294
14. B.E. van Aken, J. Jansen, S.J. van Deventer, and P.H. Reitsma Elevated levels of homocysteine increase IL-6 production in monocytic Mono Mac 6 cells Blood Coagul Fibrinolysis 11 2000 159 164
15. S. Dalal, S.M. Parkin, S. Homer-Vanniasinkam, and A. Nicolaou Effect of homocysteine on cytokine production by human endothelial cells and monocytes Ann Clin Biochem 40 Pt. 5 2003 534 541
16. J.B. Meigs, P.F. Jacques, J. Selhub, D.E. Singer, D.M. Nathan, and N. Rifai Framingham Offspring Study. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham Offspring Study Diabetes Care 24 2001 1403 1410
17. M. Emoto, H. Kanda, T. Shoji, T. Kawagishi, M. Komatsu, and K. Mori Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes Diabetes Care 24 2001 533 538
18. O.A. Mojiminiyi, N. Abdella, M.A. Moussa, A.O. Akanji, H. Al Mohammedi, and M. Zaki Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus Diabetes Res Clin Pract 58 2002 37 44
19. M. Erren, H. Reinecke, R. Junker, M. Fobker, H. Schulte, and J.O. Schurek Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries Arterioscler Thromb Vasc Biol 19 1999 2355 2363
20. A. Araki, and H. Ito Asymptomatic cerebral infarction on brain MR images and cognitive function in elderly diabetic patients Geriatr Gerontol Int 2 2002 206 214
21. A. Araki, and Y. Sako Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection J Chromatogr 422 1987 43 52
22. R.L. Starkie, J. Rolland, D.J. Angus, M.J. Anderson, and M.A. Febbraio Circulating monocytes are not the source of elevations in plasma IL-6 and TNF-α levels after prolonged running Am J Physiol Cell Physiol 280 2001 C769 C774
23. N. Rifai, R.P. Tracy, and P.M. Ridker Clinical efficacy of an automated high-sensitivity C-reactive protein assay Clin Chem 45 1999 2136 2141
24. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
25. P. Frosst, H.J. Blom, R. Milos, P. Goyette, C.A. Sheppard, and R.G. Matthews A candidate genetic risk factor for vascular disease: a common mutation in methylene tetrahydrofolate reductase Nat Genet 10 1995 111 113
26. J. Ma, M.J. Stampfer, C.H. Hennekens, P. Frosst, J. Selhub, and J. Horsford Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians Circulation 94 1996 2410 2416
27. B. Christensen, P. Frosst, S. Lussier-Cacan, J. Selhub, P. Goyette, and D.S. Rosenblatt Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease Arterioscler Thromb Vasc Biol 17 1997 569 573
28. J. Ma, M.J. Stampfer, C.H. Hennekens, P. Frosst, J. Selhub, and J. Horsford Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians Circulation 94 1996 2410 2416
29. S. Heidenreich, R. Junker, H. Wolters, D. Lang, S. Hessing, and G. Nitsche Outcome of kidney transplantation in patients with inherited thrombophilia: data of a prospective study J Am Soc Nephrol 14 2003 234 239
30. A. Dicker-Brown, V.A. Fonseca, L.M. Fink, and P.A. Kern The effect of glucose and insulin on the activity of methylenetetrahydrofolate reductase and cystathionine-beta-synthase: studies in hepatocytes Atherosclerosis 158 2001 297 301
31. A. Desai, H.A. Lankford, and J.S. Warren Homocysteine augments cytokine-induced chemokine expression in human vascular smooth muscle cells: implications for atherogenesis Inflammation 25 2001 179 186
32. X. Zeng, J. Dai, D.G. Remick, and X. Wang Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes Circ Res 93 2003 311 320
33. K.B. Holven, P. Aukrust, T. Holm, L. Ose, and M.S. Nenseter Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects Arterioscler Thromb Vasc Biol 22 2002 699 703
34. M.A. Hofmann, E. Lalla, Y. Lu, M.R. Gleason, B.M. Wolf, and N. Tanji Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model J Clin Invest 107 2001 675 683